金沙检测线路js95(中国)股份有限公司-Official website

You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
Company News
Company News Brief News on Innovation
Company News
PEIJIA MEDICAL'S LICENSING PARTNER, JENAVALVE TECHNOLOGY, INC., IS ACQUIRED BY EDWARDS LIFESCIENCES, MARKING A NEW CHAPTER IN THE TRANSCATHETER TREATMENT OF AORTIC REGURGITATION
2024.07.25
PEIJIA MEDICAL'S LICENSING PARTNER, JENAVALVE TECHNOLOGY, INC., IS ACQUIRED···

Peijia Medical commented on the acquisition of JenaValve Technology, Inc. ("···
Peijia Medical Announced Proposed Share Repurchase in the Open Market
2024.06.21
Peijia Medical Announced Proposed Share Repurchase in the Open Market

On June 20, Peijia Medical announced that the Board resolved to repurchase share···
Peijia Medical Announced Audited 2023 Annual Results and Resumption of Trading
2024.06.17
Peijia Medical Announced Audited 2023 Annual Results and Resumption of Trad···

On June 16, Peijia Medical released the announcement of its audited results for ···
Nearly a Hundred Investors and Analysts Attended the Peijia Medical Corporate Day, Immersing Themselves in the 'hardcore' Company Culture
2024.06.11
Nearly a Hundred Investors and Analysts Attended the Peijia Medical Corpora···

In late May 2024, Peijia Medical successfully held its 2024 Corporate Day and th···
PEIJIA MEDICAL ANNOUNCED  UNAUDITED 2023 ANNUAL RESULTS
2024.03.29
PEIJIA MEDICAL ANNOUNCED UNAUDITED 2023 ANNUAL RESULTS

On March 28, 2024, Peijia Medical announced that it would delay the publication ···
VOLUNTARY ANNOUNCEMENTUNAUDITED OPERATING STATISTICSFOR THE YEAR ENDED DECEMBER 31, 2023
2024.01.26
VOLUNTARY ANNOUNCEMENTUNAUDITED OPERATING STATISTICSFOR THE YEAR ENDED DECE···

This announcement is made by Peijia Medical Limited (the “Company”, together wit···
Peijia Medical Presented Multiple Pipeline Products at TCT 2023 Conference
2023.10.31
Peijia Medical Presented Multiple Pipeline Products at TCT 2023 Conference

Transcatheter Cardiovascular Therapeutics 2023 (TCT 2023) conference, the annual···
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2023 TO JUNE 30, 2023
2023.07.24
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2023 TO JUNE ···

UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2022 TO DECEMBER 31, 2022
2023.01.18
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2022 TO DECEM···

Peijia Medical Announced 2021 Annual Results
2022.04.06
Peijia Medical Announced 2021 Annual Results

On March 31, 2022, Peijia Medical Limited (“Peijia Medical” or the “Company”, to···
Peijia Medical Obtained Exclusive License for JenaValve’s TrilogyTM TAVR System for Treating AR in  the Greater China Region
2022.02.07
Peijia Medical Obtained Exclusive License for JenaValve’s TrilogyTM TAVR Sy···

Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investm···
Peijia Medical Announces 2021 Interim Results
2021.08.31
Peijia Medical Announces 2021 Interim Results

Peijia Medical Announces 2021 Interim ResultsTAVR products TaurusOne® and T···
Top
XML 地图